Pharming (PHAR) Revenue (2020 - 2026)

Pharming's Revenue history runs 7 years deep, the most recent figure standing at $72.4 million for Q1 2026.

• Quarterly Revenue rose 91595975.56% year-over-year to $72.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $169.7 million (up 30.9% YoY) and the FY2025 annual result came in at $376.1 million, up 26.56% from the prior year.
• Revenue was $72.4 million for Q1 2026 at Pharming, up from $106.5 in the prior quarter.
• Across five years, Revenue topped out at $151.0 million in Q4 2022 and bottomed at $55.59 in Q1 2024.
• A 5-year average of $47.5 million and a median of $46.6 million in 2022 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue sank 100.0% — and 2025, when it jumped 130080113.9%.
• Pharming's Revenue stood at $151.0 million in 2022, then tumbled by 100.0% to $81.2 in 2023, then surged by 151.85% to $204.5 in 2024, then slumped by 47.92% to $106.5 in 2025, then jumped by 68025252.11% to $72.4 million in 2026.
• Business Quant data shows PHAR's Revenue at $72.4 million in Q1 2026, $106.5 in Q4 2025, and $97.3 million in Q3 2025.